NRD
Nebula Research & Development’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Buy |
+900
| New | +$293K | 0.03% | 795 |
|
|
2023
Q4 | – | Sell |
-2,089
| Closed | -$370K | – | 630 |
|
|
2023
Q3 | $370K | Buy |
+2,089
| New | +$370K | 0.2% | 210 |
|
|
2023
Q2 | – | Sell |
-1,162
| Closed | -$233K | – | 332 |
|
|
2023
Q1 | $233K | Buy |
+1,162
| New | +$233K | 0.41% | 149 |
|